{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:37:24Z","timestamp":1794472644014,"version":"4.9.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.survophthal.2009.02.002","type":"journal-article","created":{"date-parts":[[2009,5,6]],"date-time":"2009-05-06T04:23:40Z","timestamp":1241583820000},"page":"321-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Topical Ophthalmic Cyclosporine: Pharmacology and\u00a0Clinical Uses"],"prefix":"10.1016","volume":"54","author":[{"given":"Eric","family":"Donnenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Pflugfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2009.02.002_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1475-1313.2004.00185.x","article-title":"A 6-month follow-up of successful refits from daily disposable soft contact lenses to continuous wear of high-Dk silicone-hydrogel lenses","volume":"24","author":"Aakre","year":"2004","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.survophthal.2009.02.002_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1076\/ceyr.18.2.91.5381","article-title":"Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs","volume":"18","author":"Acheampong","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2009.02.002_bib3","first-page":"2506","article-title":"Tear fluid gelatinase B activity correlates with IL-1 concentration and fluorescein clearance in ocular rosacea","volume":"40","author":"Afonso","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib5","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/S0161-6420(97)30015-3","article-title":"Ocular rosacea: patient characteristics and follow-up","volume":"104","author":"Akpek","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3928\/1081-597X-20020301-02","article-title":"Effect of laser in situ keratomileusis for hyperopia on tear film and ocular surface","volume":"18","author":"Albietz","year":"2002","journal-title":"J Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcrs.2003.07.003","article-title":"Chronic dry eye and regression after laser in situ keratomileusis for myopia","volume":"30","author":"Albietz","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1523-1747.2002.01709.x","article-title":"Localization of calcineurin\/NFAT in human skin and psoriasis and inhibition of calcineurin\/NFAT activation in human keratinocytes by cyclosporin A","volume":"118","author":"Al-Daraji","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3928\/1081-597X-20000501-10","article-title":"Decreased tear secretion after laser in situ keratomileusis for high myopia","volume":"16","author":"Aras","year":"2000","journal-title":"J Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000050876","article-title":"Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis","volume":"215","author":"Avunduk","year":"2001","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2009.02.002_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1189\/jlb.0904486","article-title":"Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis","volume":"77","author":"Banerjee","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib12","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"Phase 3 safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib13","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","article-title":"Inflammatory cytokines in the tears of patients with ocular rosacea","volume":"104","author":"Barton","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00006324-200001000-00012","article-title":"Responses of contact lens wearers to a dry eye survey","volume":"77","author":"Begley","year":"2000","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome: a Delphi approach to treatment recommendations","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"issue":"2 Suppl 2","key":"10.1016\/j.survophthal.2009.02.002_bib16","first-page":"644","article-title":"Treatment of severe vernal keratoconjunctivitis with cyclosporine A eyedrops","volume":"20","author":"BenEzra","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2009.02.002_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/26.4.285","article-title":"Cyclosporin A in the treatment of severe Beh\u00e7et's uveitis","volume":"26","author":"Binder","year":"1987","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.micinf.2005.03.003","article-title":"Early events in HSV keratitis\u2014setting the stage for a blinding disease","volume":"7","author":"Biswas","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.survophthal.2009.02.002_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0161-6420(91)32069-4","article-title":"Topical cyclosporine in vernal keratoconjunctivitis","volume":"98","author":"Bleik","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib20","first-page":"4133","article-title":"Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone","volume":"41","author":"Bourcier","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib21","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib22","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.icl.0000086492.28723.0C","article-title":"Effects of soft contact lenses on conjunctival surface","volume":"29","author":"Cakmak","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2009.02.002_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00003226-200403000-00014","article-title":"Topical cyclosporine in the management of shield ulcers","volume":"23","author":"Cetinkaya","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10384-004-0098-3","article-title":"Effect of immunosuppression on survival of allograft limbal stem cells","volume":"48","author":"Chen","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/bjo.84.11.1244","article-title":"Mooren's ulcer in China: a study of clinical characteristics and treatment","volume":"84","author":"Chen","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2009.02.002_bib27","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0092-8674(02)00699-2","article-title":"NFAT signaling: choreographing the social lives of cells","volume":"109","author":"Crabtree","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2009.02.002_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib29","first-page":"7","article-title":"Cyclosporin A: a new era in organ transplantation","volume":"10","author":"DeBakey","year":"1984","journal-title":"Compr Ther"},{"key":"10.1016\/j.survophthal.2009.02.002_bib30","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bjo.81.12.1107","article-title":"Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A","volume":"81","author":"Dick","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajo.2005.08.035","article-title":"Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis","volume":"141","author":"Doan","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jcrs.2003.09.043","article-title":"Effect of hinge width on corneal sensation and dry eye after laser in situ keratomileusis","volume":"30","author":"Donnenfeld","year":"2004","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(03)00100-3","article-title":"The effect of hinge position on corneal sensation and dry eye after LASIK","volume":"110","author":"Donnenfeld","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","article-title":"Meibomian gland dysfunction","volume":"40","author":"Driver","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1167\/iovs.04-1022","article-title":"Cyclosporin a inhibits calcineurin\/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells","volume":"46","author":"Eckstein","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0161-6420(91)32154-7","article-title":"Immunopathology of atopic keratoconjunctivitis","volume":"98","author":"Foster","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib37","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","article-title":"Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A","volume":"89","author":"Fruman","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2009.02.002_bib38","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00003226-199811000-00014","article-title":"The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporin a therapy","volume":"17","author":"Gao","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1099320","article-title":"The pathophysiology of mitochondrial cell death","volume":"305","author":"Green","year":"2004","journal-title":"Science"},{"issue":"5 Suppl 35","key":"10.1016\/j.survophthal.2009.02.002_bib40","first-page":"S101","article-title":"Benefit\/risk of cyclosporine in rheumatoid arthritis","volume":"22","author":"Gremese","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 67","key":"10.1016\/j.survophthal.2009.02.002_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.0366-077X.2004.05949.x","article-title":"Ciclosporin in psoriasis clinical practice: an international consensus statement","volume":"150","author":"Griffiths","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sj\u00f6gren's syndrome","volume":"72","author":"Gund\u00fcz","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.survophthal.2009.02.002_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000268041","article-title":"Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis","volume":"29","author":"Gund\u00fcz","year":"1997","journal-title":"Ophthalmic Res"},{"issue":"Pt 1","key":"10.1016\/j.survophthal.2009.02.002_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2009.02.002_bib45","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0041-1345(98)00577-6","article-title":"Calcineurin and the biological effect of cyclosporine and tacrolimus","volume":"30","author":"Halloran","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2009.02.002_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1399-0012.1991.tb00142.x","article-title":"Concentration of cyclosporin-A and its metabolites in transplanted human kidney tissue during rejection and stable graft function","volume":"5","author":"Hanas","year":"1991","journal-title":"Clin Transplant"},{"key":"10.1016\/j.survophthal.2009.02.002_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004170050257","article-title":"Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study","volume":"237","author":"Heiligenhaus","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib48","first-page":"392","article-title":"The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis","volume":"40","author":"Hingorani","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib49","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":"A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib50","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0161-6420(90)32403-X","article-title":"Ocular rosacea: a histologic and immunopathologic study","volume":"97","author":"Hoang-Xuan","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.icl.0000175651.30487.58","article-title":"Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients","volume":"32","author":"Hom","year":"2006","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2009.02.002_bib52","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1083\/jcb.200111073","article-title":"NFAT: ubiquitous regulator of cell differentiation and adaptation","volume":"156","author":"Horsley","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0161-6420(02)01081-3","article-title":"Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders","volume":"109","author":"Ilari","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","article-title":"Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty","volume":"44","author":"Inoue","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib55","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.jcrs.2004.01.020","article-title":"Survey of complications and recommendations for management in dissatisfied patients seeking a consultation after refractive surgery","volume":"30","author":"Jabbur","year":"2004","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib56","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis","volume":"41","author":"Kili\u00e7","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0886-3350(99)80085-6","article-title":"Change in corneal sensitivity following laser in situ keratomileusis","volume":"25","author":"Kim","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib58","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ophtha.2004.12.036","article-title":"Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy","volume":"112","author":"Kiss","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib59","doi-asserted-by":"crossref","first-page":"13367","DOI":"10.1074\/jbc.273.22.13367","article-title":"Regulation of the calmodulin-stimulated protein phosphatase, calcineurin","volume":"273","author":"Klee","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2009.02.002_bib60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1582-4934.2004.tb00321.x","article-title":"Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease","volume":"8","author":"Kountouras","year":"2004","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.survophthal.2009.02.002_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib62","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"3 Suppl 4","key":"10.1016\/j.survophthal.2009.02.002_bib63","first-page":"128","article-title":"Cyclosporine in the treatment of birdshot retinochoroidopathy","volume":"20","author":"Le Hoang","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.survophthal.2009.02.002_bib64","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1167\/iovs.06-0985","article-title":"A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection","volume":"48","author":"Lee","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.ico.0000208818.47861.1d","article-title":"Ophthalmic cyclosporine use in ocular GVHD","volume":"25","author":"Lelli","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib66","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archopht.1984.01040030434019","article-title":"Association of rosacea and keratoconjunctivitis sicca","volume":"102","author":"Lemp","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib67","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1167\/iovs.04-0299","article-title":"Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells","volume":"45","author":"Li","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt\u00a01","key":"10.1016\/j.survophthal.2009.02.002_bib68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/BJ20040669","article-title":"Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis","volume":"383","author":"Li","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.survophthal.2009.02.002_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","article-title":"Herpes simplex virus epidemiology and ocular importance","volume":"20","author":"Liesegang","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib70","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/0929867043455576","article-title":"Inhibitors of the calcineurin\/NFAT pathway","volume":"11","author":"Martinez-Martinez","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.survophthal.2009.02.002_bib71","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Beh\u00e7et's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2009.02.002_bib72","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ncb1203-1041","article-title":"Calcium orchestrates apoptosis","volume":"5","author":"Mattson","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib73","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0091-6749(97)70279-3","article-title":"T-cell cytokines in chronic allergic eye disease","volume":"100","author":"Metz","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib74","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2222.2004.1950.x","article-title":"No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis","volume":"34","author":"Nivenius","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.survophthal.2009.02.002_bib75","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(14)76692-9","article-title":"Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis","volume":"112","author":"Nussenblatt","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib76","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00003226-200310001-00004","article-title":"Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation","volume":"22","author":"Ogawa","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib77","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1021227019915","article-title":"Long-term therapy with low dose cyclosporin A in ocular Beh\u00e7et's disease","volume":"105","author":"Ozdal","year":"2002","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3928\/1081-597X-20010101-02","article-title":"Corneal sensitivity and some properties of the tear film after laser in situ keratomileusis","volume":"17","author":"Patel","year":"2001","journal-title":"J Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib80","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0002-9394(98)00444-9","article-title":"Corneal sensitivity after photorefractive keratectomy and laser in situ keratomileusis for low myopia","volume":"127","author":"Perez-Santonja","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib81","first-page":"159","article-title":"Topical cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber","volume":"24","author":"Perry","year":"1998","journal-title":"CLAO J"},{"key":"10.1016\/j.survophthal.2009.02.002_bib82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.ico.0000176611.88579.0a","article-title":"Efficacy of commercially available topical cyclosporine a 0.05% in the treatment of meibomian gland dysfunction","volume":"25","author":"Perry","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib83","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/S0161-6420(03)00538-4","article-title":"Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis","volume":"110","author":"Perry","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2009.02.002_bib85","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00003226-200009000-00009","article-title":"The diagnosis and management of dry eye: a twenty-five-year review","volume":"19","author":"Pflugfelder","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib86","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0161-6420(00)00347-X","article-title":"Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca","volume":"107","author":"Pisella","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib87","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1001\/jama.286.22.2787","article-title":"Progress in the treatment of rheumatoid arthritis","volume":"286","author":"Pisetsky","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.survophthal.2009.02.002_bib87a","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib88","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","article-title":"Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis","volume":"89","author":"Pucci","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib89","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajo.2005.11.042","article-title":"Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%","volume":"141","author":"Rao","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib90","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine .05% in the treatment of dry eye associated with graft versus host disease","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004170050204","article-title":"Topical cyclosporin A in Thygeson's superficial punctate keratitis","volume":"237","author":"Reinhard","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib92","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1046\/j.1365-2230.2002.01148.x","article-title":"Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology","volume":"27","author":"Reynolds","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib93","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/ICO.0b013e318074e460","article-title":"Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye","volume":"26","author":"Roberts","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib94","first-page":"14","article-title":"Dry eye symptoms following cataract surgery","volume":"32","author":"Roberts","year":"2007","journal-title":"Insight"},{"key":"10.1016\/j.survophthal.2009.02.002_bib95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.2006.22.47","article-title":"Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis","volume":"22","author":"Rubin","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2009.02.002_bib96","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","article-title":"Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis","volume":"32","author":"Salib","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2009.02.002_bib97","first-page":"631","volume":"107","author":"Sall","year":"2000","journal-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib98","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/hep.1840150619","article-title":"Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection","volume":"15","author":"Sandborn","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib99","first-page":"37","article-title":"Clinical response does not correlate with intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine","volume":"91","author":"Sandborn","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib101","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/107999000312441","article-title":"Interleukin-6 levels in tears of contact lens wearers","volume":"20","author":"Schultz","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.survophthal.2009.02.002_bib102","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib103","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archopht.1995.01100100054027","article-title":"Ocular surface changes and discomfort in patients with meibomian gland dysfunction","volume":"113","author":"Shimazaki","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib104","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/10807680260362696","article-title":"Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease","volume":"18","author":"Small","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2009.02.002_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ico.0000141486.56931.9b","article-title":"The tear film complex: pathogenesis and emerging therapies for dry eyes","volume":"24","author":"Smith","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib106","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib107","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1399-3038.2006.00427.x","article-title":"Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood","volume":"17","author":"Spadavecchia","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399400001769","article-title":"Molecular targets for existing and novel immunosuppressive drugs","volume":"2","author":"Stepkowski","year":"2000","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.survophthal.2009.02.002_bib109","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib110","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sj\u00f6gren's and non-Sj\u00f6gren's patients with dry eye","volume":"43","author":"Stern","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2009.02.002_bib111","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib112","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.icu.0000143683.14738.76","article-title":"Ocular rosacea: an update on pathogenesis and therapy","volume":"15","author":"Stone","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib113","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003226-200401000-00020","article-title":"Oral tetracyclines for ocular rosacea: an evidence-based review of the literature","volume":"23","author":"Stone","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib114","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jnr.20292","article-title":"Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?","volume":"79","author":"Sullivan","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.survophthal.2009.02.002_bib116","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.survophthal.2009.02.002_bib117","first-page":"1105","article-title":"Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors","volume":"17","author":"Tichelli","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2009.02.002_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(01)00959-X","article-title":"Dry eye after laser in situ keratomileusis","volume":"132","author":"Toda","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib119","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archopht.120.8.1024","article-title":"Laser-assisted in situ keratomileusis for patients with dry eye","volume":"120","author":"Toda","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2009.02.002_bib121","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.survophthal.2009.02.002_bib122","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2174\/0929867033457160","article-title":"Cyclophilin D as a drug target","volume":"10","author":"Waldmeier","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.survophthal.2009.02.002_bib123","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.284.5412.339","article-title":"Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD","volume":"284","author":"Wang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2009.02.002_bib124","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0161-6420(94)31087-6","article-title":"Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis","volume":"101","author":"Wilhelmus","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2009.02.002_bib125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0952-7915(03)00050-5","article-title":"Calcium signalling in lymphocytes","volume":"15","author":"Winslow","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib126","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1475-1313.2002.00066.x","article-title":"A multi-centre study of lapsed contact lens wearers","volume":"22","author":"Young","year":"2002","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.survophthal.2009.02.002_bib127","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9394(14)73872-3","article-title":"Local therapy of corneal allograft rejection with cyclosporine","volume":"119","author":"Zhao","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2009.02.002_bib128","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00003226-200111000-00019","article-title":"Quantification of MUC5AC protein in human tears","volume":"20","author":"Zhao","year":"2001","journal-title":"Cornea"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962570900037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962570900037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:33:54Z","timestamp":1758540834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003962570900037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S003962570900037X"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2009.02.002","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Ophthalmic Cyclosporine: Pharmacology and\u00a0Clinical Uses","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2009.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}